{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:39:22Z","timestamp":1773095962387,"version":"3.50.1"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1001\/jamaneurol.2018.2215","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T12:32:14Z","timestamp":1534163534000},"page":"1511","source":"Crossref","is-referenced-by-count":23,"title":["Association of Intracranial Hemorrhage Risk With Non\u2013Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use"],"prefix":"10.1001","volume":"75","author":[{"given":"Wen-Yi","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Neurology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Keelung Branch, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Singer","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ling","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Population Health Sciences, National Health Research Institutes, Miaoli County, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[{"name":"General Clinical Research Center, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsu-Huei","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Ovbiagele","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of South Carolina, Charleston"},{"name":"Now with Department of Neurology, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"noi180055r1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000177034","article-title":"Six-year survival and causes of death among stroke patients in Korea.","volume":"32","author":"Kim","year":"2009","journal-title":"Neuroepidemiology"},{"key":"noi180055r2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7525-8-49","article-title":"The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS).","volume":"8","author":"Cadilhac","year":"2010","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"noi180055r3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/STROKEAHA.109.573543","article-title":"Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"issue":"9","key":"noi180055r4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"noi180055r5","doi-asserted-by":"publisher","first-page":"j5058","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"issue":"23","key":"noi180055r6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"noi180055r7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/ijs.12630","article-title":"Design of randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate vs acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT ESUS).","volume":"10","author":"Diener","year":"2015","journal-title":"Int J Stroke"},{"issue":"9","key":"noi180055r8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1747493016681019","article-title":"Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design.","volume":"12","author":"Geisler","year":"2017","journal-title":"Int J Stroke"},{"issue":"4","key":"noi180055r9","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1161\/STROKEAHA.117.020059","article-title":"Atrial cardiopathy and the risk of ischemic stroke in the CHS (cardiovascular health study).","volume":"49","author":"Kamel","year":"2018","journal-title":"Stroke"},{"issue":"11","key":"noi180055r10","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1161\/STROKEAHA.115.009989","article-title":"Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan study.","volume":"46","author":"Kamel","year":"2015","journal-title":"Stroke"},{"issue":"5","key":"noi180055r11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.v78.5","article-title":"Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study.","volume":"78","author":"Kamel","year":"2015","journal-title":"Ann Neurol"},{"key":"noi180055r12","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"13","key":"noi180055r13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves.","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"noi180055r15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/CIRCOUTCOMES.114.001606","article-title":"Intracranial hemorrhage after ischemic stroke: incidence, time trends, and predictors in a Swedish nationwide cohort of 196 765 patients.","volume":"8","author":"\u00d6gren","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"noi180055r16","doi-asserted-by":"publisher","first-page":"e88131","DOI":"10.1371\/journal.pone.0088131","article-title":"Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.","volume":"9","author":"Lopes","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"noi180055r17","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"noi180055r18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7650","key":"noi180055r19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"14","key":"noi180055r20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"noi180055r21","first-page":"S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.","author":"Anand","year":"2017","journal-title":"Lancet"},{"issue":"13","key":"noi180055r22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism.","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"noi180055r23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1474-4422(12)70017-0","article-title":"Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial.","volume":"11","author":"Diener","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi180055r24","doi-asserted-by":"publisher","first-page":"e004301","DOI":"10.1136\/bmjopen-2013-004301","article-title":"Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation.","volume":"4","author":"Cameron","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"noi180055r25","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","article-title":"Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.","volume":"46","author":"Yaghi","year":"2015","journal-title":"Stroke"},{"issue":"3","key":"noi180055r26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1212\/WNL.0b013e31829bfde3","article-title":"Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review.","volume":"81","author":"Tsai","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"noi180055r27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S1474-4422(05)70325-2","article-title":"Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003.","volume":"5","author":"Feigin","year":"2006","journal-title":"Lancet Neurol"},{"key":"noi180055r14","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2696416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T11:04:41Z","timestamp":1544439881000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.2215"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.2215","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733814603.793554628","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}